Cargando…

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of sickle cell disease (SCD) as it improves treatment outcomes. However, despite the benefits of HU, its uptake among SCD patients in Nigeria remains low. Objective: This study aimed to assess the perception and experie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chianumba, Reuben Ikechukwu, Ofakunrin, Akinyemi O. D., Morrice, Jack, Olanrewaju, Olaniyi, Oniyangi, Oluseyi, Kuliya-Gwarzo, Aisha, Nnebe-Agumadu, Uche, Isa, Hezekiah Alkali, Nnodu, Obiageli Eunice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987287/ https://www.ncbi.nlm.nih.gov/pubmed/35401653 http://dx.doi.org/10.3389/fgene.2022.826132

Ejemplares similares

Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria
por: Isa, Hezekiah Alkali, et al.
Publicado: (2022)

Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders
por: Isa, Hezekiah, et al.
Publicado: (2023)

Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey
por: Okocha, Emmanuel Chide, et al.
Publicado: (2022)

Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
por: Nnodu, Obiageli E, et al.
Publicado: (2020)

Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example
por: Nnodu, Obiageli, et al.
Publicado: (2022)

Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria
por: Okeke, Chinwe O., et al.
Publicado: (2022)

Contribution of malaria and sickle cell disease to anaemia among children aged 6–59 months in Nigeria: a cross-sectional study using data from the 2018 Demographic and Health Survey
por: Chao, Dennis L, et al.
Publicado: (2022)

The association of transfusion status with antioxidant enzymes and malondialdehyde level in Nigerians with sickle cell disease
por: Abiodun, Emokpae Mathias, et al.
Publicado: (2014)

Associations between perceived value of exclusive breastfeeding among pregnant women in the United States and exclusive breastfeeding to three and six months postpartum: a prospective study
por: Nnebe-Agumadu, Uche H., et al.
Publicado: (2016)

Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability
por: Ryan, Nessa, et al.
Publicado: (2020)

The Influence of Decreased Levels of High Density Lipoprotein Cholesterol on Hematological Indices in Sickle Cell Disease Patients
por: Emokpae, AM, et al.
Publicado: (2014)

Evaluating laboratory request forms submitted to haematology and blood transfusion departments at a hospital in Northwest Nigeria
por: Jegede, Feyisayo, et al.
Publicado: (2016)

Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria
por: Ofakunrin, Akinyemi O D, et al.
Publicado: (2019)

Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria
por: Ofakunrin, Akinyemi OD, et al.
Publicado: (2021)

Hematological parameters of human immunodeficiency virus positive pregnant women on antiretroviral therapy in Aminu Kano Teaching Hospital Kano, North Western Nigeria
por: Abdulqadir, Ibrahim, et al.
Publicado: (2018)

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges
por: Nnodu, Obiageli, et al.
Publicado: (2019)

S269: MALE PATIENTS WITH SCD HAVE A HIGHER RISK OF CEREBROVASCULAR DISEASE, INCREASED INFLAMMATORY MARKERS, AND POORER RESPONSE TO HYDROXYUREA
por: DI Mauro, Margherita, et al.
Publicado: (2023)

The Effects of Treatment with Blood Transfusion, Iron Chelation and Hydroxyurea on Puberty, Growth and Spermatogenesis in Sickle Cell Disease (SCD): A short update
por: Soliman, Ashraf T, et al.
Publicado: (2021)

P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
por: C., SEGBEFIA, et al.
Publicado: (2022)

P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS
por: P., BARTOLUCCI, et al.
Publicado: (2022)

Malignant skin lesions in Oshogbo, Nigeria
por: Oseni, Ganiyu Oyediran, et al.
Publicado: (2015)

World Coalition on SCD launches, sparking global focus on SCD diagnosis and care
por: Zapfel, Andrew, et al.
Publicado: (2023)

Fine needle aspiration cytology of bone tumours- the experience from the National Orthopaedic and Lagos University Teaching Hospitals, Lagos, Nigeria
por: Nnodu, Obiageli E, et al.
Publicado: (2006)

P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
por: Allard, P., et al.
Publicado: (2022)

Hydroxyurea Induced Perimalleolar Ulcers
por: Saravu, Kavitha, et al.
Publicado: (2006)

Mutagenic and Genotoxic Effect of Hydroxyurea
por: Santos, Jean L., et al.
Publicado: (2011)

Blue Lunula Related with Hydroxyurea
por: Üsküdar Teke, Hava, et al.
Publicado: (2013)

The Cell Killing Mechanisms of Hydroxyurea
por: Singh, Amanpreet, et al.
Publicado: (2016)

Hydroxyurea-induced Tooth Discoloration
por: Okuyucu, Muhammed, et al.
Publicado: (2020)

Hydroxyurea—The Good, the Bad and the Ugly
por: Musiałek, Marcelina W., et al.
Publicado: (2021)

Hydroxyurea-Induced Acute Pancreatitis
por: Bath, Harjot, et al.
Publicado: (2022)

Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium
por: Nnodu, Obiageli Eunice, et al.
Publicado: (2022)

Editorial: Building capacity for sickle cell disease research and healthcare
por: Nembaware, Victoria, et al.
Publicado: (2023)

Multiple myeloma in Nigeria: a multi-centre epidemiological and biomedical study
por: Nnonyelum, Odunukwe Nkiruka, et al.
Publicado: (2015)

Effect of Sickle Cell Trait on Human Immunodeficiency Virus Type 1 Infection
por: Okpala, Iheanyi, et al.
Publicado: (2022)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

Nitric Oxide Generation from Hydroxyurea via Copper‐catalyzed Peroxidation and Implications for Pharmacological Actions of Hydroxyurea
por: Sato, Keizo, et al.
Publicado: (1997)

Elevated levels of sCD48 are inversely correlated with markers of disease activity in bullous pemphigoid
por: Treco, Emma, et al.
Publicado: (2022)

Proceedings: DNA synthesis in the presence of hydroxyurea.
por: Brown, J. S., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_bdbdlrtbqpggvmajohqrminm4f